2315 Stockton Blvd.
Sacramento, CA 95817
Ph.D., City University of New York, New York, New York, 1990
B.A./B.S., University of Rochester, Rochester, New York, 1984
American Board of Pediatrics, General Pediatrics, 2010
California Thoracic Society
Massachusetts Medical Society
Society for Critical Care Medicine
Select Honors and Awards:
Pasadena Top Doctors, 2010
Sigma Xi, Mt. Sinai School of Medicine Chapter, 1988
Select Recent Publications:
Doki T, Mello M, Mock D, Evans JM and Kearns-Jonker, M., Intragraft gene expression profile associated with the induction of tolerance, BMC Immunol. 2008 Feb 11;9:5.
Evans JM , Doki T, Fischer-Lougheed J, Davicioni E and Kearns-Jonker M, WTC06: Expression Changes in Tolerant Cardiac Allografts after Gene Therapy with a Lentiviral Vector Expressing ?1,3 Galactosyltransferase, Transplantation Proceedings, 38:3172-3180, 2006.
Evans J and Cohen G, Catecholamine Uptake Inhibitors Elevate 6-Hydroxydopamine in Brain After Administration of 6-hydroxydopa. Eur J Pharmacol, 232:241-245, 1993.
Cohen G and Evans J, Vesicular Binding of 6-Hydroxydopamine Does Not Explain the Resistance of Dopamine Nerve Terminals to 6-Hydroxydopa. Neurodegeneration, 1:241-246, 1992.
Evans JM and Cohen G, Can Trace Amounts of Neurotoxins Destroy Dopamine Neurons? Neurochemistry International, 15:127-129, 1989.
Evans JM and Cohen G, Studies on the Formation of 6-Hydroxydopamine in Brain After the Administration of 2,4,5-Trihydroxyphenylalanine (6-HydroxyDOPA). J. Neurochem, 52:1461-1467, 1989.